Wegovy, a highly effective medication used to treat obesity, shows promise in treating a serious form of liver disease in a ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial. The Fox Medical Team's Dr. Mike Cirigliano joined Good Day to take a look ...

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

Chances are, you haven’t heard of metabolic dysfunction–associated steatohepatitis (MASH)—but you’ve almost definitely heard ...

Novo Nordisk’s Wegovy (semaglutide injection) 2.4mg has demonstrated early protection against heart disease, according to new ...

Discover how metabolic dysfunction-associated steatohepatitis (MASH) damages your liver, its connection to common health ...

As the definitive trial comparing Wegovy to Mounjaro is released, experts stress the need for patients to be given the very ...

Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared ...

How does Wegovy (or any form of 2.4 mg dose of semaglutide ... Patient education: Metabolic dysfunction-associated steatotic liver disease (Beyond the Basics). UpToDate.